It's a good thing. I also think they need to pivot back to a narrower focus on goat formula IMO. But whether the product is good or bad is kind of irrelevant if they have not figured out a China distribution strategy that doesn't hinge on daigou.
Ann: Bubs Q3 FY24 Quarterly Activity and Cashflow Statement, page-83
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $160.7M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $68.24K | 383.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 125189 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 560087 | 21 |
View Market Depth
| Last trade - 10.34am 27/06/2025 (20 minute delay) ? |
| BUB (ASX) Chart |